Condition

Hypogonadism

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 39 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials39

Recruiting1

Common interventions25

Lead sponsors shown15

Clinical trials

39 shown

Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomyNCT04833426 · 2022-12-12

Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer PatientsNCT07535905 · 2026-07-01

NOT_YET_RECRUITING

Testosterone Therapy and Bone Quality in Men With Diabetes and HypogonadismNCT03887936 · 2019-10-01

Hypothalamic-pituitary Dysfunction in DiabetesNCT05752591 · 2018-05-25

Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes MellitusNCT03437109 · 2017-12-06

Long-term Lifestyle Change and Testosterone ReplacementNCT03256292 · 2017-08-21

Effects of Testosterone on Myocardial RepolarizationNCT03126656 · 2016-09-01

Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)NCT02959853 · 2016-06-01

Association Between Testosterone Levels and COPD SeverityNCT02824809 · 2016-06-01

Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic SyndromeNCT02672592 · 2016-01-01

Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.NCT03619330 · 2014-12-01

MRI Substudy; Metabolic Changes Due to Iatrogenic HypogonadismNCT02102646 · 2014-04-01

Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With HypogonadismNCT01084369 · 2013-10-11

Testosterone, Metformin, or Both, for Hypogonadism in Obese MalesNCT02514629 · 2013-07-04

Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron TreatmentNCT02111434 · 2013-07-01

Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric PatientsNCT02248467 · 2013-05-01

Study of the Prevalence and Associated Factors With Hypogonadism in HIV + MenNCT02665559 · 2013-01-01

Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM)NCT01560546 · 2012-03-01

Testosterone Therapy in Heart FailureNCT01377103 · 2011-07-01

Testosterone Replacement in Men With Diabetes and ObesityNCT01127659 · 2010-05-01

Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic HypogonadismNCT00624624 · 2009-09-01

Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and DiabetesNCT00440440 · 2009-08-01

Reandron in Diabetic Men Witn Low Testosterone LevelNCT00613782 · 2009-01-01

Estrogen Dosing in Turner Syndrome: Pharmacology and MetabolismNCT00837616 · 2009-01-01

Androgen Deprivation Therapy StudyNCT00743327 · 2008-10-01

Effect of Testosterone Replacement on Insulin ResistanceNCT00487734 · 2007-08-01

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant RecipientsNCT00504218 · 2007-07-17

Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male PatientsNCT00847314 · 2007-06-01

Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low TestosteroneNCT00392912 · 2007-04-01

Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid TherapyNCT01061970 · 2007-01-01

Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese MenNCT00365794 · 2006-08-01

Testosterone for Men With Insulin Treated Type 2 DiabetesNCT00349362 · 2006-07-01

Testosterone for Peripheral Vascular DiseaseNCT00504712 · 2006-02-01

Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 DiabetesNCT00141492 · 2004-10-01

Testosterone Replacement in Older Men and Atherosclerosis ProgressionNCT00287586 · 2004-09-01

Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.NCT00104572 · 2004-03-01

Testosterone Replacement in Metabolic Syndrome and InflammationNCT01123278 · 2004-01-01

Prevention of Osteoporosis in Men With Prostate CancerNCT00048841 · 2002-05-01

Estrogen Treatment (Oral vs. Patches) in Turner SyndromeNCT00140998 · 2001-01-01

Common interventions

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

placebo10 testosterone8 testosterone undecanoate2 alendronate1 anakinra1 liraglutide1 metformin1 pioglitazone1 tamoxifen1 triptorelin1

Leading sponsors

Barnsley Hospital 2 Baylor College of Medicine 2 National Institute on Aging (NIA) 2 Nemours Children's Clinic 2 University of Roma La Sapienza 2 Austin Health 1 Bayer 1 Besins Healthcare 1 Brigham and Women's Hospital 1 Canisius-Wilhelmina Hospital 1 Cedars-Sinai Medical Center 1 Diabetes Center of the Southwest 1 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1 Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 1 Gulhane School of Medicine 1

Trial status mix

COMPLETED31

TERMINATED3

WITHDRAWN2

NOT_YET_RECRUITING1

RECRUITING1

UNKNOWN1

Phase mix

PHASE416

PHASE26

PHASE36

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.